FDA NDC

PROMACTA

This name is from the loaded FDA file.

Source: FDA NDC Directory, live from openFDA. Publisher page

NDC
0078-0972
Proprietary name
PROMACTA
Nonproprietary name
eltrombopag olamine
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
POWDER, FOR SUSPENSION
Strength
12.5 mg/1

Run it in Rivvi

Which 2027 plans near you dropped or restricted eltrombopag olamine?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Try it on your own data today.

Free to start. Most teams are using it the same day.